Tradestie Institutional Equity Comparison Engine

SNYR vs ACAD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACAD Overall Edge

ACAD Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Acadia Pharmaceuticals Inc. (ACAD) driven by superior Growth & Margin, Momentum & Technical while SNYR counters with relative strength in Valuation, Options & Structure. Fundamentally, SNYR trades at 0.6x Forward P/E with -10.3% operating margin (-32.8% YoY revenue) versus ACAD at 15.8x Forward P/E and 10.2% operating margin (+22.8% YoY). In options structure, SNYR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ACAD sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SNYR
SNYR 0.6x vs ACAD 15.8x Fwd P/E
Growth & Margin Winner ACAD
Op Margin -10.3% vs 10.2% ยท YoY -32.8% vs +22.8%
Momentum & Technical Winner ACAD
1Y -96.2% vs -25.9% ยท 52W Pos 1% vs 8%
Options & Structure Winner SNYR
UNCLASSIFIED (N/A IV) vs BREAKDOWN (6th %ile IV)
SNYR NASDAQ
Synergy CHC Corp. Common Stock
Medicinal Chemicals & Botanical Products
$0.09
-67.02% 1D
Market Cap $4.1M
1M Return -16.28%
1Y Return -96.15%
Forward P/E 0.6x
Unified AI Score
48.9 / 100 HOLD
Tech 55.0 Fund 39.0 Flow 50.0 Mom 60.0
ACAD NASDAQ
Acadia Pharmaceuticals Inc.
Pharmaceutical Preparations
$17.11
-2.73% 1D
Market Cap $3.0B
1M Return -15.76%
1Y Return -25.93%
Forward P/E 15.8x
Unified AI Score
44.8 / 100 HOLD
Tech 38.0 Fund 54.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SNYR -96.15% ACAD -25.93% Spread: +114.96 pp (ACAD Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SNYR Revenue ACAD Revenue SNYR Op. Margin ACAD Op. Margin Margin Edge
FY2018 $30M $220M -14.5% -110.6% SNYR
FY2019 $30M $340M -27.1% -72.7% SNYR
FY2020 N/A $440M N/A -64.9% ACAD
FY2021 N/A $480M N/A -35.2% ACAD
FY2022 N/A $520M N/A -43.2% ACAD
FY2023 $40M $730M 25.3% -10.1% SNYR
FY2024 $30M $960M 16.7% 24.1% ACAD
FY2025 $30M $1.07B -27.8% 9.8% ACAD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SNYR (3) vs ACAD (7)
Institutional Metric SNYR ACAD Criterion Row Winner
Market Capitalization Scale $4.1M $3.0B Larger Scale ACAD
Trailing P/E Ratio Valuation 0.6x 8.3x Lower Multiple SNYR
Forward P/E Ratio Valuation 0.6x 15.8x Lower Multiple SNYR
Revenue Growth (YoY) Growth -32.8% +22.8% Higher Growth ACAD
Operating Margin (TTM) Profitability -10.3% 10.2% Higher Margin ACAD
Net Profit Margin Profitability -57.0% 30.1% Higher Margin ACAD
Return on Equity (ROE) Capital Efficiency -361.1% 31.4% Higher ROE ACAD
52-Week Range Position Momentum 1% ($0โ€“$3) 8% ($16โ€“$31) Stronger Trend ACAD
Beta / 30D Volatility Risk Regime -0.86ฮฒ ยท 868% Vol 0.15ฮฒ ยท 90% Vol Lower Realized Risk ACAD
Unified Institutional Score Composite Signal 48.9 / 100 (HOLD) 44.8 / 100 (HOLD) Higher Composite SNYR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SNYR vs ACAD Buy Guide
SNYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SNYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ACAD BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live ACAD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SNYR nor ACAD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.